Prices are updated after-hours


Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date

tags : Disease    save search

Valued to be $12.9 Billion by 2026, Crohn`s Disease (CD) Therapy Slated for Robust Growth Worldwide
Published: 2022-06-27 (Crawled : 12:20) - prnewswire.com
NVO | News | $112.89 0.69% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.97% C: 0.19%
CCXI | News | $26.01 -0.53% -4.4% | twitter stocktwits trandingview |
Health Technology
| | O: -4.88% H: 1.04% C: -1.25%
AZN | News | $66.465 -0.65% -0.42% | twitter stocktwits trandingview |
Health Technology
| | O: -0.36% H: 1.22% C: 0.38%
AZNCF | News | $129.21 | twitter stocktwits trandingview |
Health Technology
| | O: -1.55% H: 4.43% C: 0.03%
NVS | News | $85.28 0.53% 0.02% | twitter stocktwits trandingview |
Health Technology
| | O: 1.86% H: 1.05% C: 0.24%
PFE | News | $51.88 0.56% 0.04% | twitter stocktwits trandingview |
Health Technology
| | O: 1.46% H: 1.45% C: 0.78%
JNJ | News | $182.12 -0.09% 0.1% | twitter stocktwits trandingview |
Health Technology
| | O: 0.78% H: 0.94% C: 0.26%

disease for therapy growth
Beam Therapeutics to Present First Research Highlighting Approach to Develop Non-Genotoxic Conditioning Regimens for Patients with Sickle Cell Disease Ahead of Autologous Transplant
Published: 2022-06-27 (Crawled : 11:00) - globenewswire.com
BEAM | News | $43.19 1.6% 1.15% | twitter stocktwits trandingview |
Health Technology
| | O: 0.21% H: 2.94% C: 0.65%

research disease for therapeutics
Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease
Published: 2022-06-27 (Crawled : 08:00) - biospace.com/
ALPMY | News | $16.205 | twitter stocktwits trandingview |
Manufacturing
| | O: -1.2% H: 0.0% C: -0.37%

at845 fda disease trial update
Astellas Announces FDA Update on the FORTIS Clinical Trial of AT845 in Adults with Late-Onset Pompe Disease
Published: 2022-06-26 (Crawled : 00:00) - prnewswire.com
ALPMY | News | $16.205 | twitter stocktwits trandingview |
Manufacturing
| | O: -1.2% H: 0.0% C: -0.37%

at845 fda disease trial update
ProKidney Corroborates the Mechanism of Action of REACT™ with Cell Marker Analysis in Patients with Diabetic Chronic Kidney Disease
Published: 2022-06-23 (Crawled : 17:00) - biospace.com/
DNAC | $9.975 0.05% 0.05% | twitter stocktwits trandingview |
| | O: 0.16% H: 0.05% C: -0.11%

disease kidney diabetic
uniQure Announces Update on Low-Dose Cohort in Phase I/II Clinical Trial of AMT-130 Gene Therapy for the Treatment of Huntington’s Disease
Published: 2022-06-23 (Crawled : 12:00) - biospace.com/
QURE S | $18.69 -2.2% -2.67% | twitter stocktwits trandingview |
Health Technology
| | O: 11.64% H: 14.76% C: 14.47%

amt-130 treatment disease for trial therapy update
Novartis renews commitment to neglected tropical disease and malaria elimination, investing USD 250 million over five years to research and develop new treatments
Published: 2022-06-23 (Crawled : 01:00) - globenewswire.com
NVS | News | $85.28 0.53% 0.02% | twitter stocktwits trandingview |
Health Technology
| | O: 0.3% H: 0.0% C: 0.0%

research disease novartis
U.S. FDA Approves Merck’s VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Infants and Children
Published: 2022-06-22 (Crawled : 17:00) - biospace.com/
MRK | News | $94.41 1.37% 0.27% | twitter stocktwits trandingview |
Health Technology
| | O: 3.24% H: 2.61% C: 1.27%

fda disease for children
Cyclerion Therapeutics to Discuss CY6463 MELAS Clinical Data at a Webinar Hosted by United Mitochondrial Disease Foundation
Published: 2022-06-22 (Crawled : 13:00) - ir.cyclerion.com
CYCN | $0.6046 14.05% 13.19% | twitter stocktwits trandingview |
Health Technology
| | O: -0.5% H: 9.6% C: 1.4%

cy6463 disease therapeutics
BioRestorative Therapies Announces Clinical Trial Contract with Second Site for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
Published: 2022-06-22 (Crawled : 12:20) - biospace.com/
BRTXQ P | $ 0% | twitter stocktwits trandingview |
Health Services
| Email alert Add to watchlist
BRTXD | $ 0% | twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist
BRTX | $3.43 -0.29% -1.16% | twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist

disease for contract trial
BridgeBio Pharma Announces Early Positive Data for BBP-812, its Investigational AAV9 Gene Therapy for Canavan Disease
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
BBIO | News A | $9.34 1.08% -0.43% | twitter stocktwits trandingview |
Health Technology
| | O: -1.02% H: 12.96% C: 8.61%

bbp-812 pharma disease for aav9 positive therapy
Athira Pharma Announces Topline Results from ACT-AD Phase 2 Proof of Concept Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Disease
Published: 2022-06-22 (Crawled : 12:00) - biospace.com/
ATHA S | $2.85 4.02% -0.37% | twitter stocktwits trandingview |
Health Technology
| | O: -69.76% H: 17.42% C: 7.95%

pharma disease topline alzheimer’s results act-ad phase 2 ath-1017
Regulus Therapeutics Announces Receipt of FDA Orphan Drug Designation for RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Published: 2022-06-21 (Crawled : 16:00) - biospace.com/
RGLS | $0.225 -6.48% 5.99% | twitter stocktwits trandingview |
Health Technology
| | O: 3.45% H: 0.0% C: 0.0%

rgls8429 treatment fda designation drug disease for kidney therapeutics
Gilead to Present Latest Data From Across Liver Disease Development Programs at the International Liver Congress™ 2022
Published: 2022-06-21 (Crawled : 14:00) - biospace.com/
GILD | $62.84 -0.38% -0.13% | twitter stocktwits trandingview |
Health Technology
| | O: 1.34% H: 0.0% C: 0.0%

liver disease international
Cyclo Therapeutics to Present at the 2022 NPC Patient and Family Conference Hosted by the Australian NPC Disease Foundation
Published: 2022-06-21 (Crawled : 13:20) - biospace.com/
CYTH | $2.1 4.76% | twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -2.68% H: 0.0% C: 0.0%

conference disease therapeutics
9 Meters Biopharma Announces Interim Analysis of Phase 3 Study of Larazotide for Celiac Disease Does Not Support Trial Continuation
Published: 2022-06-21 (Crawled : 13:00) - biospace.com/
NMTR A | $0.4011 5.55% -7.9% | twitter stocktwits trandingview |
Health Technology
| | O: -53.55% H: 0.0% C: 0.0%

biopharma disease for trial
ANI Pharmaceuticals Adopts Veeva Commercial Cloud to Better Support Rare Disease Patients
Published: 2022-06-21 (Crawled : 12:00) - biospace.com/
VEEV S | $208.07 0.5% 0.0% | twitter stocktwits trandingview |
Technology Services
| | O: 4.75% H: 0.0% C: 0.0%
ANIP | $30.095 4.1% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 2.34% H: 0.0% C: 0.0%

rare disease commercial cloud
Ocugen Announces Publication of Positive Results of COVID-19 Vaccine Trial for Children 2-18 in The Lancet Infectious Diseases
Published: 2022-06-21 (Crawled : 12:00) - biospace.com/
OCGN | $2.435 -2.99% -0.8% | twitter stocktwits trandingview |
Health Technology
| | O: 10.89% H: 0.0% C: 0.0%

covid-19 for children vaccine lancet trial positive results publication disease
SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
Published: 2022-06-21 (Crawled : 11:00) - biospace.com/
SQZ | $3.37 -4.53% 2.97% | twitter stocktwits trandingview |
Health Technology
| | O: 2.92% H: 0.0% C: 0.0%

disease preclinical sqz immunology meeting
Emergent BioSolutions Announces Publication of CHIKV VLP Phase 2 Safety and Immunogenicity Data in The Lancet Infectious Diseases
Published: 2022-06-21 (Crawled : 11:00) - globenewswire.com
EBS | $32.65 -0.34% 0.0% | twitter stocktwits trandingview |
Health Technology
| | O: 5.29% H: 0.0% C: 0.0%

lancet publication chikungunya disease
Your saved searches
Save your searches and get alerts when important news are released.

Mentioned Today
ABBV | News | $153.14 0.53% 0.04% | twitter stocktwits trandingview |
Health Technology

APPN | News 4 | $54.46 -1.05% 0.38% | twitter stocktwits trandingview |
Technology Services

APPS | News | $17.62 1.62% 5.48% | twitter stocktwits trandingview |
Technology Services

APYX | News | $6.04 1.51% 0.0% | twitter stocktwits trandingview |
Health Technology

BNPQF | News | $50.78 | twitter stocktwits trandingview |
Finance

BNPQY | News | $25.46 | twitter stocktwits trandingview |
Finance and Insurance

BNPZY | News | $ 0% | twitter stocktwits trandingview |
Finance and Insurance

CNXC | News | $147.67 1.63% -0.04% | twitter stocktwits trandingview |
Information

CNXCV | News | $2.27 0% | twitter stocktwits trandingview |
Commercial Services

DMYD | News | $16.21 0% | twitter stocktwits trandingview |
Finance

DMYT | News | $22.76 0% | twitter stocktwits trandingview |
Finance

DRE | News | $56.17 -2.23% 0.0% | twitter stocktwits trandingview |
Finance

EPZM | News | $1.47 54.09% 7.97% | twitter stocktwits trandingview |
Health Technology

ET | News | $10.14 0.4% 0.59% | twitter stocktwits trandingview |
Industrial Services

FBNC | News | $35.7 2.32% 0.0% | twitter stocktwits trandingview |
Finance

FBP | News | $13.52 0.67% 0.0% | twitter stocktwits trandingview |
Finance

FTRP | News | $0.81 1.25% 0.0% | twitter stocktwits trandingview |
Health Care and Social Assistan...

GRRB | News | $30.6 | twitter stocktwits trandingview |
Finance and Insurance

HR | News | $27.23 1.38% 0.0% | twitter stocktwits trandingview |
Finance

HTA | News | $27.7 -0.22% 0.0% | twitter stocktwits trandingview |
Finance

IE | News 0 d new | $ 0% | twitter stocktwits trandingview |
n/a

IONQ | News | $4.83 -5.48% 2.07% | twitter stocktwits trandingview |
Professional, Scientific, and T...

LLY | News 4 | $327.27 0.51% 0.04% | twitter stocktwits trandingview |
Health Technology

LMPX | News | $4.62 0.43% 0.0% | twitter stocktwits trandingview |
Technology Services

NFLX | News | $189.14 -0.9% 0.52% | twitter stocktwits trandingview |
Consumer Services

OBCI | News | $12.86 0.0% | twitter stocktwits trandingview |
Consumer Non-Durables

OMC | News | $64.75 0.23% 0.0% | twitter stocktwits trandingview |
Commercial Services

ONEW | News | $35.25 3.68% 0.0% | twitter stocktwits trandingview |
Retail Trade

OSCR | News | $4.55 2.94% 0.0% | twitter stocktwits trandingview |

PACB | News | $5.3 -5.53% -1.78% | twitter stocktwits trandingview |
Health Technology

PEGA | News | $51.68 -1.97% 0.0% | twitter stocktwits trandingview |
Technology Services

PFHC | News | $19.75 6.35% -4.95% | twitter stocktwits trandingview |

PLD | News | $120.21 -1.94% 0.54% | twitter stocktwits trandingview |
Finance

PSORF | News | $9.55 0% | twitter stocktwits trandingview |
Consumer Services

RDUS | News | $10.205 0.94% -0.4% | twitter stocktwits trandingview |
Health Technology

SNY | News | $52.62 -1.5% -0.41% | twitter stocktwits trandingview |
Health Technology

SNYNF | News | $104.5 | twitter stocktwits trandingview |
Health Technology

SPRO | News | $0.931 -0.96% 3.19% | twitter stocktwits trandingview |
Health Technology

SREV | News | $1.45 -2.76% | twitter stocktwits trandingview |
Technology Services

TGTX | News | $4.34 -1.36% -2.05% | twitter stocktwits trandingview |
Health Technology

TUP | News 4 | $7.16 1.42% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

USAK | News | $30.85 -0.48% -0.39% | twitter stocktwits trandingview |
Transportation

USWS | News | $0.995 4.08% -0.63% | twitter stocktwits trandingview |
Finance

VRCA | News | $2.195 4.03% 10.43% | twitter stocktwits trandingview |
Health Technology

WWE | News | $61.0 0.63% 0.0% | twitter stocktwits trandingview |
Consumer Services

XRAY | News | $36.74 -0.05% 0.0% | twitter stocktwits trandingview |
Health Technology

ZEN | News | $74.65 0.65% -0.07% | twitter stocktwits trandingview |
Technology Services